Thanks Bear - 

For this and the other article (conceptual framework one with the nice diagram).  I was able to get to the abstract page, but not the full text.  Eventually they will be accessible though.  Any chance you could add both of these links to the link library or off-topic discussion if you haven't already?  Thanks! 

Also - understanding that these other compounds (AbbieVie, GSK, others) may or may not work as well or better, and may or may not have fewer side effects, assuming they are successful in either comparable or greater measure - (plus they have more funding to move faster) - what is your sense of how that would affect apabetalone's chances (and those of the other compounds that Resverlogix/Zenith supposedly have?).

Thanks!